mCODE™ Initiative Collaborators

Many Stakeholders Collaborate to Develop mCODE

mCODE is governed by the mCODE Executive Committee, a small, agile group of four to seven public and private entities who have voluntarily come together to further mCODE adoption.

The mCODE Executive Committee members include:

 

Join the mCODE Council

This is a standing group that provides thought leadership for mCODE, advises the Executive Committee, sponsors use cases, and promotes mCODE adoption. The Council also consults on new and amended data elements and use cases for the mCODE core data specification and its extensions. Individual Council members may participate in implementation pilots.

Membership in the Council is at the organization level and is subject to approval by the Executive Committee. View the current Council Roster.

If your organization is interested in being considered for membership in the Council, please complete and submit the application form.

Ongoing Implementation Pilots to Test mCODE

Many organizations are collaborating on pilots to enable, test, and advance mCODE use. Activities include:

  • ICAREdata™ study: The mCODE team is working with the Alliance for Clinical Trials in Oncology on the Integrating Clinical Trials and Real-World Endpoints (ICARE) data project. ICAREdata aims to demonstrate that mCODE-based real-world data can drive more efficient clinical research by incorporating the data for a broader population of patients while maintaining the same quality as traditional clinical trials.
  • Compass™: MITRE has developed Compass, an mCODE-based FHIR implementation and Substitutable Medical Applications and Reusable Technologies (SMART)-on-FHIR application. Intermountain Healthcare is testing Compass to extract mCODE data elements from EHRs to create reports for providers and patients that can be used to make shared treatment decisions based on which treatments worked for similar cohorts of patients.
  • Camino™: MITRE is also developing Camino, a SMART-on-FHIR application that provides computable standards-based clinical pathways. Navigation through the protocol is driven by mCODE data elements accessible from the EHR. Camino allows the oncologist to see both where the patient is on the pathway and recommended treatment options.

Submit a Use Case Proposal

mCODE employs a use case development model, and these use cases help to expand the mCODE data dictionary. mCODE defines a “use case” as a defined set of oncology clinical circumstances for which certain common data elements can be described and identified as useful. A data element is a discrete piece of oncology clinical information, identified by reference to a use case, that is expressed in a structured, computable field. Anyone can submit a use case proposal.

Each proposal for a new use case will be reviewed by the mCODE Technical Review Group and must be approved by the mCODE Executive Committee. The Technical Review Group will work with users to refine use cases, consult on implementation, and advise on quality improvement matters. Once the Technical Review Group has done an initial review of the proposed use care, further development work (i.e., data modeling and implementation testing) may be referred to a new Working Group created by the Executive Committee or to the Common Oncology Data Elements eXtensions (CodeX) launched within the HL7 Fast Healthcare Interoperability Resources (FHIR) Accelerator program at the end of 2019.

Please see the mCODE Submitted Use Case Review Process for an overview of the use case proposal and data element review and approval process.

Submit a use case proposal.

We’re looking for more collaborators with the same passion and dedication to bring mCODE to its full potential. Please contact mcode-info@asco.org for more information.

    Founding Members

    ASCO and CancerLinQ

    ASCO and CancerLinQ

    The American Society of Clinical Oncology, Inc. (ASCO®) is a leading group of oncologists who stand at the forefront of cancer clinical insight and experience. CancerLinQ®, a subsidiary of ASCO, operates a robust quality monitoring system of cancer data analyses. Together, these groups are helping to convene the cancer community and will provide the leadership, clinical insight, data capabilities, and standardization needed to build and scale mCODE. CancerLinQ also provides its expertise in health information technology, operations, and specific clinical subject matter to support the development and piloting of mCODE for specific use cases.

    The MITRE Corporation

    The MITRE Corporation

    MITRE’s mission is to solve problems for a safer world. It is a public interest, not-for-profit organization that manages federally funded research and development centers for the government. MITRE has a unique vantage point working across federal, state, and local government, as well as with industry and academia. In this partnership, MITRE provides expertise in health IT, interoperability, standards development, and prototyping to drive the technical design, development, and testing capabilities necessary for building and iterating the interoperable structure of mCODE. MITRE is developing an mCODE-based Fast Healthcare Interoperability Resources (FHIR) implementation and Substitutable Medical Applications and Reusable Technologies (SMART)-on-FHIR application that will extract mCODE data in computable formats and deliver reports to providers, patients, and other stakeholders.

    Every Patient's Journey Can Improve All Future Care

    Interested in joining the mCODE Council? Submit your application online.

    Contact Us

    mCODE™ is a trademark of the American Society of Clinical Oncology.

    Privacy Policy | Terms